X @Bloomberg

Shares of Eli Lilly and Novo Nordisk fell after US regulators established a “green list” of foreign manufacturers who produce raw materials that compounding pharmacies use to make copies of their blockbuster GLP-1 drugs https://t.co/o4f2nB4gxN ...